Emmanuel J Favaloro Shares A Study on AI and Machine Learning in Thrombosis and Hemostasis
Emmanuel J Favaloro, Lead Scientist at the Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, shared on LinkedIn:
”Latest publication from the Sydney Centres for Thrombosis and Haemostasis.
This one ably led by one of my Charles Sturt University (CSU) PhD students, Mohammad Altememi, based at Liverpool Hospital, NSW Health Pathology, and his primary supervisor Prof. Abishek B. Santhakumar, with additional co-supervision from another of my CSU colleagues, Md Zahid Islam.
Free to download from that great Q1 journal Clinical Chemistry and Laboratory Medicine.”
Read the full article here.
Article: Artificial intelligence and machine learning in thrombosis and hemostasis: a scoping review of clinical and laboratory applications, challenges, and future directions
Authors: Mohammad A. Altememi, Emmanuel J Favaloro, Zahid Islam, Abishek. B. Santhakumar
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 18, 2026, 16:22Heghine Khachatryan: Navigating the New Era of Hemophilia Gene Therapy
-
Mar 18, 2026, 16:21Georges Chahoud: Top Take-Home Messages from the AHA/ACC/Multisociety Acute PE Guideline
-
Mar 18, 2026, 16:19Cedric Hermans: Unleashing the Potential of Physical Activity in Hemophilia A Patients
-
Mar 18, 2026, 16:17Asif Mushtaq: Managing Cardiac Surgery with Cardiopulmonary Bypass in Hemophilia
-
Mar 18, 2026, 16:15Amir Kraitzer: Engineering Hemocompatible Surfaces to Overcome Thrombosis in Medical Devices
-
Mar 18, 2026, 16:11Hemant Sharma: Advancing Neonatal Care with New Strategies to Prevent IVH
-
Mar 18, 2026, 16:09Yves Bikorimana: How a Simple Temperature Change Can Trigger Antibody-Mediated Destruction of RBCs
-
Mar 18, 2026, 16:07Scott Isaacs: Optimizing Brain Vitality and Slowing Neurodegeneration Through Daily Habits
-
Mar 18, 2026, 16:05Daniel Lorenzatti: EAT is not Just a Bystander but Also a Great Modifiable Therapeutic Target